Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,240 | -25,170 | -53,630 | -39,044 | 0 |
| Depreciation Amortization | 247 | 116 | 400 | 296 | 0 |
| Accounts receivable | 278 | 17 | N/A | 157 | 0 |
| Accounts payable and accrued liabilities | 4,199 | 5,807 | N/A | -2,145 | 0 |
| Other Working Capital | 41,690 | 25,103 | 41,410 | 26,340 | 0 |
| Other Operating Activity | 18,354 | 8,872 | 27,240 | 24,833 | 0 |
| Operating Cash Flow | $14,528 | $14,745 | $15,420 | $10,437 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,553 | -260 | -370 | -225 | 0 |
| Net Acquisitions | 2,334 | 2,334 | 0 | N/A | 0 |
| Investing Cash Flow | $781 | $2,074 | $-370 | $-225 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 9,950 | 0 |
| Common Stock Issued | 19 | 10 | N/A | 6 | 0 |
| Common Stock Repurchased | -2 | -2 | N/A | N/A | 0 |
| Other Financing Activity | 53,957 | 0 | 9,950 | 0 | 0 |
| Financing Cash Flow | $53,974 | $8 | $9,950 | $9,956 | $0 |
| Exchange Rate Effect | 32 | -64 | 0 | N/A | 0 |
| Beginning Cash Position | 39,554 | 39,554 | 14,540 | 14,548 | 0 |
| End Cash Position | 108,869 | 56,317 | 39,550 | 34,716 | 0 |
| Net Cash Flow | $69,315 | $16,763 | $25,000 | $20,168 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,528 | 14,745 | 15,420 | 10,437 | 0 |
| Capital Expenditure | -1,553 | -260 | N/A | -225 | 0 |
| Free Cash Flow | 12,975 | 14,485 | 15,420 | 10,212 | 0 |